Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Electroporation-enhanced transdermal diclofenac sodium delivery into the knee joint in a rat model of acute arthritis.

Hartmann P, Butt E, Fehér Á, Szilágyi ÁL, Jász KD, Balázs B, Bakonyi M, Berkó S, Erős G, Boros M, Horváth G, Varga E, Csányi E.

Drug Des Devel Ther. 2018 Jun 27;12:1917-1930. doi: 10.2147/DDDT.S161703. eCollection 2018.

2.

Mapping integration of midwives across the United States: Impact on access, equity, and outcomes.

Vedam S, Stoll K, MacDorman M, Declercq E, Cramer R, Cheyney M, Fisher T, Butt E, Yang YT, Powell Kennedy H.

PLoS One. 2018 Feb 21;13(2):e0192523. doi: 10.1371/journal.pone.0192523. eCollection 2018.

3.

Residential energy use emissions dominate health impacts from exposure to ambient particulate matter in India.

Conibear L, Butt EW, Knote C, Arnold SR, Spracklen DV.

Nat Commun. 2018 Feb 12;9(1):617. doi: 10.1038/s41467-018-02986-7.

4.

Predicament in Detection and Reporting of Extended Spectrum Beta Lactamase Production in Routine Antibiotic Susceptibility Testing.

Butt T, Raza S, Butt E.

J Coll Physicians Surg Pak. 2017 Dec;27(12):788-790. doi: 2776.

PMID:
29185411
5.

Oxidant sensor in the cGMP-binding pocket of PKGIα regulates nitroxyl-mediated kinase activity.

Donzelli S, Goetz M, Schmidt K, Wolters M, Stathopoulou K, Diering S, Prysyazhna O, Polat V, Scotcher J, Dees C, Subramanian H, Butt E, Kamynina A, Schobesberger S, King SB, Nikolaev VO, de Wit C, Leichert LI, Feil R, Eaton P, Cuello F.

Sci Rep. 2017 Aug 30;7(1):9938. doi: 10.1038/s41598-017-09275-1.

6.

Deletion of Batf3-dependent antigen-presenting cells does not affect atherosclerotic lesion formation in mice.

Gil-Pulido J, Cochain C, Lippert MA, Schneider N, Butt E, Amézaga N, Zernecke A.

PLoS One. 2017 Aug 3;12(8):e0181947. doi: 10.1371/journal.pone.0181947. eCollection 2017.

7.

Protein kinase A activation by the anti-cancer drugs ABT-737 and thymoquinone is caspase-3-dependent and correlates with platelet inhibition and apoptosis.

Rukoyatkina N, Butt E, Subramanian H, Nikolaev VO, Mindukshev I, Walter U, Gambaryan S, Benz PM.

Cell Death Dis. 2017 Jun 29;8(6):e2898. doi: 10.1038/cddis.2017.290.

8.

Influence of hematuria and infection on diagnostic accuracy of urinary LASP1: a new biomarker for bladder carcinoma.

Butt E, Ebbing J, Bubendorf L, Ardelt P.

Biomark Med. 2017 Apr;11(4):347-357. doi: 10.2217/bmm-2016-0348. Epub 2017 Mar 14.

PMID:
28290211
9.

Population exposure to hazardous air quality due to the 2015 fires in Equatorial Asia.

Crippa P, Castruccio S, Archer-Nicholls S, Lebron GB, Kuwata M, Thota A, Sumin S, Butt E, Wiedinmyer C, Spracklen DV.

Sci Rep. 2016 Nov 16;6:37074. doi: 10.1038/srep37074.

10.

Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1).

Endres M, Kneitz S, Orth MF, Perera RK, Zernecke A, Butt E.

Oncotarget. 2016 Sep 27;7(39):64244-64259. doi: 10.18632/oncotarget.11720.

11.

The cytoskeletal protein LASP-1 differentially regulates migratory activities of choriocarcinoma cells.

Segerer SE, Bartmann C, Kaspar S, Müller N, Kapp M, Butt E, Kämmerer U.

Arch Gynecol Obstet. 2016 Feb;293(2):407-14. doi: 10.1007/s00404-015-3830-y. Epub 2015 Aug 2.

PMID:
26232936
12.

LASP1, a Newly Identified Melanocytic Protein with a Possible Role in Melanin Release, but Not in Melanoma Progression.

Vaman V S A, Poppe H, Houben R, Grunewald TG, Goebeler M, Butt E.

PLoS One. 2015 Jun 10;10(6):e0129219. doi: 10.1371/journal.pone.0129219. eCollection 2015.

13.

An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker protein.

Orth MF, Cazes A, Butt E, Grunewald TG.

Oncotarget. 2015 Jan 1;6(1):26-42. Review.

14.
15.

LASP1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia.

Frietsch JJ, Kastner C, Grunewald TG, Schweigel H, Nollau P, Ziermann J, Clement JH, La Rosée P, Hochhaus A, Butt E.

Oncotarget. 2014 Jul 30;5(14):5257-71.

16.

The Zyxin-related protein thyroid receptor interacting protein 6 (TRIP6) is overexpressed in Ewing's sarcoma and promotes migration, invasion and cell growth.

Grunewald TG, Willier S, Janik D, Unland R, Reiss C, Prazeres da Costa O, Buch T, Dirksen U, Richter GH, Neff F, Burdach S, Butt E.

Biol Cell. 2013 Nov;105(11):535-47. doi: 10.1111/boc.201300041. Epub 2013 Sep 18.

PMID:
24033704
17.

Derivation and validation of a simple, accurate and robust prediction rule for risk of mortality in patients with Clostridium difficile infection.

Butt E, Foster JA, Keedwell E, Bell JE, Titball RW, Bhangu A, Michell SL, Sheridan R.

BMC Infect Dis. 2013 Jul 12;13:316. doi: 10.1186/1471-2334-13-316.

18.
19.

Emergence and global spread of epidemic healthcare-associated Clostridium difficile.

He M, Miyajima F, Roberts P, Ellison L, Pickard DJ, Martin MJ, Connor TR, Harris SR, Fairley D, Bamford KB, D'Arc S, Brazier J, Brown D, Coia JE, Douce G, Gerding D, Kim HJ, Koh TH, Kato H, Senoh M, Louie T, Michell S, Butt E, Peacock SJ, Brown NM, Riley T, Songer G, Wilcox M, Pirmohamed M, Kuijper E, Hawkey P, Wren BW, Dougan G, Parkhill J, Lawley TD.

Nat Genet. 2013 Jan;45(1):109-13. doi: 10.1038/ng.2478. Epub 2012 Dec 9.

20.

Lessons from community-based payment for ecosystem service schemes: from forests to rangelands.

Dougill AJ, Stringer LC, Leventon J, Riddell M, Rueff H, Spracklen DV, Butt E.

Philos Trans R Soc Lond B Biol Sci. 2012 Nov 19;367(1606):3178-90. doi: 10.1098/rstb.2011.0418.

21.

Nuclear import of LASP-1 is regulated by phosphorylation and dynamic protein-protein interactions.

Mihlan S, Reiß C, Thalheimer P, Herterich S, Gaetzner S, Kremerskothen J, Pavenstädt HJ, Lewandrowski U, Sickmann A, Butt E.

Oncogene. 2013 Apr 18;32(16):2107-13. doi: 10.1038/onc.2012.216. Epub 2012 Jun 4.

PMID:
22665060
22.

The oligopeptide DT-2 is a specific PKG I inhibitor only in vitro, not in living cells.

Gambaryan S, Butt E, Kobsar A, Geiger J, Rukoyatkina N, Parnova R, Nikolaev VO, Walter U.

Br J Pharmacol. 2012 Oct;167(4):826-38. doi: 10.1111/j.1476-5381.2012.02044.x.

23.

Lasp-1 regulates podosome function.

Stölting M, Wiesner C, van Vliet V, Butt E, Pavenstädt H, Linder S, Kremerskothen J.

PLoS One. 2012;7(4):e35340. doi: 10.1371/journal.pone.0035340. Epub 2012 Apr 13.

24.

LASP-1, a novel urinary marker for detection of bladder cancer.

Ardelt P, Grünemay N, Strehl A, Jilg C, Miernik A, Kneitz B, Butt E.

Urol Oncol. 2013 Nov;31(8):1591-8. doi: 10.1016/j.urolonc.2012.02.002. Epub 2012 Apr 4.

PMID:
22481019
25.

STEAP1 is associated with the invasive and oxidative stress phenotype of Ewing tumors.

Grunewald TG, Diebold I, Esposito I, Plehm S, Hauer K, Thiel U, da Silva-Buttkus P, Neff F, Unland R, Müller-Tidow C, Zobywalski C, Lohrig K, Lewandrowski U, Sickmann A, Prazeres da Costa O, Görlach A, Cossarizza A, Butt E, Richter GH, Burdach S.

Mol Cancer Res. 2012 Jan;10(1):52-65. doi: 10.1158/1541-7786.MCR-11-0524. Epub 2011 Nov 11.

26.

Defining the role of TRIP6 in cell physiology and cancer.

Willier S, Butt E, Richter GH, Burdach S, Grunewald TG.

Biol Cell. 2011 Dec 1;103(12):573-91. doi: 10.1042/BC20110077. Review.

PMID:
22054418
27.

Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation.

Wangorsch G, Butt E, Mark R, Hubertus K, Geiger J, Dandekar T, Dittrich M.

BMC Syst Biol. 2011 Oct 28;5:178. doi: 10.1186/1752-0509-5-178.

28.

Quantification of cAMP and cGMP analogs in intact cells: pitfalls in enzyme immunoassays for cyclic nucleotides.

Werner K, Schwede F, Genieser HG, Geiger J, Butt E.

Naunyn Schmiedebergs Arch Pharmacol. 2011 Aug;384(2):169-76. doi: 10.1007/s00210-011-0662-6. Epub 2011 Jun 29.

29.

Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastoma.

Traenka C, Remke M, Korshunov A, Bender S, Hielscher T, Northcott PA, Witt H, Ryzhova M, Felsberg J, Benner A, Riester S, Scheurlen W, Grunewald TG, von Deimling A, Kulozik AE, Reifenberger G, Taylor MD, Lichter P, Butt E, Pfister SM.

Cancer Res. 2010 Oct 15;70(20):8003-14. doi: 10.1158/0008-5472.CAN-10-0592. Epub 2010 Oct 5.

30.

Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer.

Frietsch JJ, Grunewald TG, Jasper S, Kammerer U, Herterich S, Kapp M, Honig A, Butt E.

Br J Cancer. 2010 May 25;102(11):1645-53. doi: 10.1038/sj.bjc.6605685. Epub 2010 May 11.

31.

Integrin-dependent translocation of LASP-1 to the cytoskeleton of activated platelets correlates with LASP-1 phosphorylation at tyrosine 171 by Src-kinase.

Traenka J, Hauck CR, Lewandrowski U, Sickmann A, Gambaryan S, Thalheimer P, Butt E.

Thromb Haemost. 2009 Sep;102(3):520-8. doi: 10.1160/TH09-03-0143.

PMID:
19718473
32.

Cell Adhesion and Transcriptional Activity - Defining the Role of the Novel Protooncogene LPP.

Grunewald TG, Pasedag SM, Butt E.

Transl Oncol. 2009 Aug 18;2(3):107-16.

33.

cGMP-dependent protein kinase modulators.

Butt E.

Handb Exp Pharmacol. 2009;(191):409-21. doi: 10.1007/978-3-540-68964-5_17. Review.

PMID:
19089338
34.

Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs.

Krüger M, Kötter S, Grützner A, Lang P, Andresen C, Redfield MM, Butt E, dos Remedios CG, Linke WA.

Circ Res. 2009 Jan 2;104(1):87-94. doi: 10.1161/CIRCRESAHA.108.184408. Epub 2008 Nov 20.

35.

The LIM and SH3 domain protein family: structural proteins or signal transducers or both?

Grunewald TG, Butt E.

Mol Cancer. 2008 Apr 17;7:31. doi: 10.1186/1476-4598-7-31.

36.

Cyclic nucleotide analogs as probes of signaling pathways.

Poppe H, Rybalkin SD, Rehmann H, Hinds TR, Tang XB, Christensen AE, Schwede F, Genieser HG, Bos JL, Doskeland SO, Beavo JA, Butt E.

Nat Methods. 2008 Apr;5(4):277-8. doi: 10.1038/nmeth0408-277. No abstract available.

PMID:
18376388
37.

Effects of maternal cold exposure and nutrient restriction on the ghrelin receptor, the GH-IGF axis, and metabolic regulation in the postnatal ovine liver.

Hyatt MA, Butt EA, Budge H, Stephenson T, Symonds ME.

Reproduction. 2008 May;135(5):723-32. doi: 10.1530/REP-07-0421. Epub 2008 Feb 27.

38.

Nuclear localization and cytosolic overexpression of LASP-1 correlates with tumor size and nodal-positivity of human breast carcinoma.

Grunewald TG, Kammerer U, Kapp M, Eck M, Dietl J, Butt E, Honig A.

BMC Cancer. 2007 Oct 23;7:198.

39.

Dynamic interaction between Src and C-terminal Src kinase in integrin alphaIIbbeta3-mediated signaling to the cytoskeleton.

Vielreicher M, Harms G, Butt E, Walter U, Obergfell A.

J Biol Chem. 2007 Nov 16;282(46):33623-31. Epub 2007 Sep 12.

40.

Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation.

Grunewald TG, Kammerer U, Winkler C, Schindler D, Sickmann A, Honig A, Butt E.

Br J Cancer. 2007 Jan 29;96(2):296-305. Epub 2007 Jan 9.

41.

Silencing of LASP-1 influences zyxin localization, inhibits proliferation and reduces migration in breast cancer cells.

Grunewald TG, Kammerer U, Schulze E, Schindler D, Honig A, Zimmer M, Butt E.

Exp Cell Res. 2006 Apr 15;312(7):974-82. Epub 2006 Jan 23. Erratum in: Exp Cell Res. 2006 Aug 1;312(13):2631.

PMID:
16430883
42.

Regulation of aldosterone production from zona glomerulosa cells by ANG II and cAMP: evidence for PKA-independent activation of CaMK by cAMP.

Gambaryan S, Butt E, Tas P, Smolenski A, Allolio B, Walter U.

Am J Physiol Endocrinol Metab. 2006 Mar;290(3):E423-33. Epub 2005 Oct 11.

43.

Phosphorylation of mouse LASP-1 on threonine 156 by cAMP- and cGMP-dependent protein kinase.

Keicher C, Gambaryan S, Schulze E, Marcus K, Meyer HE, Butt E.

Biochem Biophys Res Commun. 2004 Nov 5;324(1):308-16.

PMID:
15465019
44.

The 97-kDa (LABD97) and 120-kDa (LAD-1) fragments of bullous pemphigoid antigen 180/type XVII collagen have different N-termini.

Hirako Y, Nishizawa Y, Sitaru C, Opitz A, Marcus K, Meyer HE, Butt E, Owaribe K, Zillikens D.

J Invest Dermatol. 2003 Dec;121(6):1554-6. No abstract available.

45.

The autoantigen of anti-p200 pemphigoid is an acidic noncollagenous N-linked glycoprotein of the cutaneous basement membrane.

Shimanovich I, Hirako Y, Sitaru C, Hashimoto T, Bröcker EB, Butt E, Zillikens D.

J Invest Dermatol. 2003 Dec;121(6):1402-8.

46.

Potent inhibition of human platelets by cGMP analogs independent of cGMP-dependent protein kinase.

Gambaryan S, Geiger J, Schwarz UR, Butt E, Begonja A, Obergfell A, Walter U.

Blood. 2004 Apr 1;103(7):2593-600. Epub 2003 Nov 26.

47.

Elimination of protein kinase MK5/PRAK activity by targeted homologous recombination.

Shi Y, Kotlyarov A, Laabeta K, Gruber AD, Butt E, Marcus K, Meyer HE, Friedrich A, Volk HD, Gaestel M.

Mol Cell Biol. 2003 Nov;23(21):7732-41.

48.

cGMP-dependent protein kinase type II regulates basal level of aldosterone production by zona glomerulosa cells without increasing expression of the steroidogenic acute regulatory protein gene.

Gambaryan S, Butt E, Marcus K, Glazova M, Palmetshofer A, Guillon G, Smolenski A.

J Biol Chem. 2003 Aug 8;278(32):29640-8. Epub 2003 May 29.

49.

Actin binding of human LIM and SH3 protein is regulated by cGMP- and cAMP-dependent protein kinase phosphorylation on serine 146.

Butt E, Gambaryan S, Göttfert N, Galler A, Marcus K, Meyer HE.

J Biol Chem. 2003 May 2;278(18):15601-7. Epub 2003 Feb 5.

50.

Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes.

Wollert KC, Fiedler B, Gambaryan S, Smolenski A, Heineke J, Butt E, Trautwein C, Lohmann SM, Drexler H.

Hypertension. 2002 Jan;39(1):87-92.

Supplemental Content

Support Center